Should internal mammary lymph nodes in breast cancer be a target for the radiation oncologist?

International Journal of Radiation Oncology Biology Physics

Volumn 46, Issue 4, 2000, Pages 805-814

  Freedman, Gary M ^a   Fowble, Barbara L ^a   Nicolaou, Nicos ^a   Sigurdson, Elin R ^a   Torosian, Michael H ^a   Boraas, Marcia C ^a   Hoffman, John P ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

Breast cancer; Extended radical mastectomy; Internal mammary lymph nodes; Radiation therapy; Sentinel lymph nodes

Indexed keywords

AXILLARY LYMPH NODE; BREAST CANCER; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SURVIVAL; FEMALE; HUMAN; LYMPH NODE; LYMPHOSCINTIGRAPHY; MASTECTOMY; PRIORITY JOURNAL; REVIEW;

EID: 0034000217     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(99)00481-2     Document Type: Article

References (61)

1. Lacour J., Le M., Caceres E., et al. Radical mastectomy versus radical mastectomy plus internal mammary dissection. Ten year results of an international cooperative trial in breast cancer. Cancer. 51:1983;1941-1943.
2. Meier P., Ferguson D.J., Karrison T. A controlled trial of extended radical versus radical mastectomy. Ten-year results. Cancer. 63:1989;188-195.
3. Kuske R.R. Adjuvant chest wall and nodal irradiation Maximize cure, minimize late cardiac toxicity . J Clin Oncol. 16:1998;2579-2582.
4. Hellman S. Stopping metastases at their source. N Engl J Med. 337:1997;996-997.
5. Overgaard M., Hansen P.S., Overgaard J., et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. N Engl J Med. 337:1997;949-955.
6. Ragaz J., Jackson S.M., Le N., et al. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med. 337:1997;956-962.
7. Overgaard M., Jensen M., Overgaard J., et al. Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen Danish Breast Cancer Cooperative Group DBCG 82c randomised trial . Lancet. 353:1999;1641-1648.
8. Livingston S.F., Arlen M. The extended extrapleural radical mastectomy Its role in the treatment of carcinoma of the breast . Ann Surg. 179:1974;260-265.
9. Urban J.A., Marjani M.A. Significance of internal mammary lymph node metastases in breast cancer. Am J Roentgenol Radium Ther Nucl Med. 3:1971;130-136.
10. Noguchi M., Ohta N., Koyasaki N., et al. Reappraisal of internal mammary node matastases as a prognostic factor in patients with breast cancer. Cancer. 68:1991;1918-1925.
11. Cáceres E. An evaluation of radical mastectomy and extended radical mastectomy for cancer of the breast. Surg Gynecol Obstet. 125:1967;337-341.
12. Donegan W.L. The influence of untreated internal mammary metastases upon the course of mammary cancer. Cancer. 39:1977;533-538.
13. Handley R.S. Carcinoma of the breast. Ann R Coll Surg Engl. 57:1975;59-66.
14. Lacour J., Bucalossi P., Cacers E., et al. Radical mastectomy versus radical mastectomy plus internal mammary dissection Five year results of an international cooperative study . Cancer. 37:1976;206-214.
15. Veronesi U., Cascinelli N., Bufalino R., et al. Risk of internal mammary lymph node metastases and its relevance on prognosis of breast cancer patients. Ann Surg. 198:1983;681-684.
16. Veronesi U., Valagussa P. Inefficacy of internal mammary nodes dissection in breast cancer surgery. Cancer. 47:1981;170-175.
17. Sugg SL, Ferguson DJ, Posner MC; et al. Should internal mammary nodes be sampled in the sentinel lymph node era? Proceedings of Society of Surgical Oncology Meeting held on March 4-7, 1999 at Orlando World Ctr., Orlando, FL. 1998;27.
18. Urban J.A. Management of operable breast cancer. The surgeon's view. Cancer. 42:1978;2066-2077.
19. O'Hea B.J., Hill A.D.K., El-Shirbiny A.M., et al. Sentinel lymph node biopsy in breast cancer Initial experience at Memorial Sloan-Kettering Cancer Center . J Am Coll Surg. 186:1998;423-427.
20. Ollila D.W., Haigh P.I., Hansen N.M., et al. Lymphatic drainage pattern of medial breast carcinomas. (Abstr.) Breast Cancer Res Treat. 50:1998;258.
21. Fleming J., Breslin T., Delpassand A., et al. The utility of preoperative lymphoscintigraphy in the management of early stage breast cancer patients receiving sentinel node biopsy. (Abstr.) Proc Am Soc Clin Oncol. 18:1999;76a.
22. Krag D., Weaver D., Ashikaga T., et al. The sentinal node in breast cancer. A multicenter validation study. N Engl J Med. 339:1998;941-946.
23. Cox C.E., Haddad F., Bass S., et al. Lymphatic mapping in the treatment of breast cancer. Oncology. 12:1998;1283-1294.
24. Veronesi U., Paganelli G., Viale G., et al. Sentinel lymph node biopsy and axillary dissection in breast cancer Results in a large series . J Natl Cancer Inst. 91:1999;368-373.
25. Fisher B., Brown A., Mamounas E., et al. Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer Findings from National Surgical Adjuvant Breast and Bowel Project B-18 . J Clin Oncol. 15:1997;2483-2493.
26. Fisher B., Redmond C., Fisher E.R., et al. Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med. 312:1985;674-681.
27. Fowble B., Gray R., Gilchrist K., et al. Identification of a subgroup of patients with breast cancer and histologically positive axillary nodes receiving adjuvant chemotherapy who may benefit from postoperative radiotherapy. J Clin Oncol. 6:1988;1107-1117.
28. Marks L.B., Halperin E.C., Prosnitz L.R., et al. Post-mastectomy radiotherapy following adjuvant chemotherapy and autologous bone marrow transplantation for breast cancer patients with ≥10 positive axillary lymph nodes. Int J Radiat Oncol Biol Phys. 23:1992;1021-1026.
29. Buzdar A.U., McNeese M.D., Hortobagyi G.N., et al. Is chemotherapy effective in reducing the local failure rate in patients with operable breast cancer? Cancer. 65:1990;394-399.
30. Stefanik D., Goldberg R., Byrne P., et al. Local-regional failure in patients treated with adjuvant chemotherapy for breast cancer. J Clin Oncol. 3:1985;660-665.
31. Freedman G.M., Fowble B.L., Hanlon A.L., et al. Postmastectomy radiation and adjuvant systemic therapy Outcomes in high-risk women with stage II-III breast cancer and assessment of clinical, pathologic, and treatment-related factors influencing ocal-regional control . Breast J. 3:1997;337-344.
32. Uematsu M., Bornstein B.A., Recht A., et al. Long-term results of post-operative radiation therapy following mastectomy with or without chemotherapy in stage I-III breast cancer. Int J Radiat Oncol Biol Phys. 25:1993;765-770.
33. Fowble B., Glick J., Goodman R. Radiotherapy for the prevention of local-regional recurrence in high risk patients post mastectomy receiving adjuvant chemotherapy. Int J Radiat Oncol Biol Phys. 15:1988;627-631.
34. Ung O., Langlands A.O., Barraclough B., et al. Combined chemotherapy and radiotherapy for patients with breast cancer and extensive nodal involvement. J Clin Oncol. 13:1995;435-443.
35. Koszarowski T. Rational approach to the efficiency of internal mammary lymph node dissection in breast cancer cure. Breast, Diseases of the Breast. 2:1976;44-47.
36. Yamashita T., Hurukawa M., Sekiguchi K., et al. Efficacy of loco-regional lymphnodes irradiation after mastectomy for breast cancer with biopsy proven parasternal lymphnodes metastases - A randomized study. (Abstr.) Int J Radiat Oncol Biol Phys. 36:1996;277.
37. Kaae S., Johansen H. Does simple mastectomy followed by irradiation offer survival comparable to radical procedures? Int J Radiat Oncol Biol Phys. 2:1977;1163-1166.
38. Arriagada R., Lê M.G., Mouriesse H., et al. Long-term effect of internal mammary chain treatment. Results of a multivariate analysis of 1195 patients with operable breast cancer and positive axillary nodes. Radiother Oncol. 11:1988;213-222.
39. Fisher B., Slack N.H., Cavanaugh P.J., et al. Postoperative radiotherapy in the treatment of breast cancer Results of the NSABP clinical trial . Ann Surg. 172:1970;711-728.
40. Høst H., Brennhovd I.O., Loeb M. Postoperative radiotherapy in breast cancer - Long-term results from the Oslo study. Int J Radiat Oncol Biol Phys. 12:1986;727-732.
41. Palmer M.K., Ribeiro G.G. Thirty four year follow-up of patients with breast cancer in clinical trial of postoperative radiotherapy. Br Med J. 291:1985;1088-1091.
42. Arriagada R., Lê M.G., Rochard F., et al. Conservative treatment versus mastectomy in early breast cancer Patterns of failure with 15 years of follow-up data . J Clin Oncol. 14:1996;1558-1564.
43. Veronesi U., Banfi A., Salvadori B., et al. Breast conservation is the treatment of choice in small breast cancer Long-term results of a randomized trial . Eur J Cancer. 26:1990;668-670.
44. Veronesi U., Zucali R., Luini A. Local control and survival in early breast cancer The Milan trial . Int J Radiat Oncol Biol Phys. 12:1986;717-720.
45. Kaija H., Maunu P. Tangential breast irradiation with or without internal mammary chain irradiation Results of a randomized trial . Radiother Oncol. 36:1995;172-176.
46. Meier P., Ferguson D.J., Karrison T.A. Controlled trial of extended radical mastectomy. Cancer. 55:1985;880-891.
47. Lacour J., Lê M.G., Hill C., et al. Is it useful to remove internal mammary nodes in operable breast cancer? Eur J Surg Oncol. 13:1987;309-314.
48. Cuzick J., Stewart H., Rutqvist L., et al. Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy. J Clin Oncol. 12:1994;447-453.
49. Effects of radiotherapy and surgery in early breast cancer. N Engl J Med. 333:1995;1444-1455.
50. Jones J.M., Ribeiro G.G. Mortality patterns over 34 years of breast cancer patients in a clinical trial of post-operative radiotherapy. Clin Radiol. 40:1989;204-208.
51. Højris I., Overgaard M., Christensen J.J., et al. Morbidity and mortality of ischemic heart disease in 3083 high-risk breast cancer patients given adjuvant systemic treatment with or without postmastectomy irradiation. (Abstr.) Radiother Oncol. 48:(Suppl. 1):1998;S120.
52. Olson J.E., Neuberg D., Pandya K.J., et al. The role of radiotherapy in the management of operable locally advanced breast carcinoma. Results of a randomized trial by the Eastern Cooperative Oncology Group. Cancer. 79:1997;1138-1149.
53. Blomqvist C., Tiusanen K., Elomaa I., et al. The combination of radiotherapy, adjuvant chemotherapy cyclophosphamide-doxorubicin-ftorafur) and tamoxifen in stage II breast cancer. Long-term follow-up results of a randomised trial. Br J Cancer. E16:1992;1171-1176.
54. Muss H.B., Cooper M.R., Brockschmidt J.K., et al. A randomized trial of chemotherapy (L-PAM vs CMF) and irradiation for node positive breast cancer. Eleven year follow-up of a Piedmont Oncology Association trial. Breast Cancer Res Treat. 19:1991;77-84.
55. Allen H., Brooks R., Jones S.E., et al. Adjuvant treatment for stage II (node positive) breast cancer with adriamycin-cyclophosphamide (AC) ±radiotherapy (XRT). Salmon S.E., Jones S.E. Adjuvant therapy for cancer III. 1981;453-562 Grune & Stratton, New York.
56. Vélez-García E., Carpenter J.T. Jr, Moore M., et al. Postsurgical adjuvant chemotherapy with or without radiotherapy in women with breast cancer and positive axillary nodes a South-Eastern Cancer Study Group (SEG) trial . Eur J Cancer. 28A:1992;1833-1837.
57. Harris J. Personal communication; 1997.
58. Arriagada R., Rutqvist L.E., Mattsson A., et al. Adequate locoregional treatment for early breast cancer may prevent secondary dissemination. J Clin Oncol. 13:1995;2689-2878.
59. Fowble B. Postmastectomy radiation Then and now . Oncology. 11:1997;213-239.
60. Recht A., Siddon R.L., Kaplan W.D., et al. Three-dimensional internal mammary lymphoscintigraphy Implications for radiation therapy treatment planning for breast carcinoma . Int J Radiat Oncol Biol Phys. 14:1988;477-481.
61. Dahl-Iversen E., Tobiassen T. Radical mastectomy with parasternal and supraclavicular dissection for mammary carcinoma. Ann Surg. 170:1969;889-891.